Compounds > raloxifene hydrochloride
Page last updated: 2024-08-23

raloxifene hydrochloride and aspartic acid

raloxifene hydrochloride has been researched along with aspartic acid in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's4 (80.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J1
Jordan, VC; Levenson, AS1
Bentrem, DJ; Jordan, VC; Liu, H; MacGregor Schafer, J; Zapf, JW1
Celik, O; Erdem, G; Hascalik, S; Karakas, HM; Tamser, M1
Anghel, SI; Auger, A; Croisetière, S; Dayan, G; Katzenellenbogen, JA; Lupien, M; Mader, S; Rocha, W1

Other Studies

5 other study(ies) available for raloxifene hydrochloride and aspartic acid

ArticleYear
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells

2007
The key to the antiestrogenic mechanism of raloxifene is amino acid 351 (aspartate) in the estrogen receptor.
    Cancer research, 1998, May-01, Volume: 58, Issue:9

    Topics: Aspartic Acid; Blotting, Northern; Breast Neoplasms; Estradiol; Estrogen Antagonists; Female; Humans; Mutagenesis, Site-Directed; Piperidines; Point Mutation; Raloxifene Hydrochloride; Receptors, Estrogen; RNA, Messenger; Transfection; Transforming Growth Factor alpha; Tumor Cells, Cultured

1998
Allosteric silencing of activating function 1 in the 4-hydroxytamoxifen estrogen receptor complex is induced by substituting glycine for aspartate at amino acid 351.
    Cancer research, 2000, Sep-15, Volume: 60, Issue:18

    Topics: Allosteric Regulation; Amino Acid Substitution; Aspartic Acid; Binding Sites; Drug Interactions; Estradiol; Estrogen Receptor Modulators; Fulvestrant; Glycine; Humans; Kinetics; Ligands; Mutagenesis, Site-Directed; Protein Conformation; Protein Structure, Tertiary; Raloxifene Hydrochloride; Receptors, Estrogen; RNA, Messenger; Tamoxifen; Transfection; Transforming Growth Factor alpha; Tumor Cells, Cultured

2000
Magnetic resonance spectroscopic comparison of the effects of resveratrol (3,4',5-trihydroxy stilbene) to conjugated equine estrogen, tibolone and raloxifene on ovariectomized rat brains.
    European journal of obstetrics, gynecology, and reproductive biology, 2005, May-01, Volume: 120, Issue:1

    Topics: Animals; Aspartic Acid; Brain; Brain Chemistry; Choline; Creatine; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Magnetic Resonance Spectroscopy; Norpregnenes; Ovariectomy; Raloxifene Hydrochloride; Rats; Rats, Wistar; Resveratrol; Stilbenes

2005
Tamoxifen and raloxifene differ in their functional interactions with aspartate 351 of estrogen receptor alpha.
    Molecular pharmacology, 2006, Volume: 70, Issue:2

    Topics: Aspartic Acid; Cell Line; Estrogen Antagonists; Estrogen Receptor alpha; Humans; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Structure-Activity Relationship; Tamoxifen

2006